{
  "num_tested_probands": [
    1,
    1,
    1,
    1
  ],
  "num_positive_het_probands": [
    0,
    0,
    0,
    0
  ],
  "positive_phenotypes": [
    [
      "infantile-onset Levodopa-responsive Parkinsonism"
    ],
    [
      "Infantile-onset Parkinsonism",
      "Dystonia",
      "Tremors in extremities responsive to Levodopa treatment"
    ],
    [
      "infantile-onset Levodopa-responsive Parkinsonism"
    ],
    [
      "Levodopa-responsive infantile-onset Parkinsonism"
    ]
  ],
  "num_compound_or_double_hets": [
    1,
    1,
    1,
    1
  ],
  "explanation": {
    "num_tested_probands": [
      "The report describes a single patient, a 17-year-old boy.",
      "The patient is the only child mentioned and tested in the report, confirmed by genetic analysis details.",
      "The report focuses on 'our patient', indicating one tested proband.",
      "The text provides information on biallelic mutations causing a specific phenotype, suggesting at least one proband was studied."
    ],
    "num_positive_het_probands": [
      "There is no mention of a proband being heterozygous for a single pathogenic variant. The boy is identified as having compound heterozygous mutations.",
      "The report described the patient as compound heterozygous for WARS2 mutations, not as a single heterozygous pathogenic variant carrier.",
      "There is no mention of a single heterozygous proband; the case discusses a compound heterozygous scenario.",
      "There is no mention of heterozygous probands; the focus is on biallelic mutations."
    ],
    "positive_phenotypes": [
      "The patient presented with infantile-onset Levodopa-responsive Parkinsonism at the age of 2 years.",
      "Phenotypes include 'Infantile-onset Parkinsonism', 'Dystonia', and 'Tremors in extremities responsive to Levodopa treatment' as described in the patient's clinical presentation.",
      "The phenotype is described as 'infantile-onset Levodopa-responsive Parkinsonism' due to WARS2 mutations.",
      "The phenotype is clearly linked to the genetic mutations: 'Levodopa-responsive infantile-onset Parkinsonism.'"
    ],
    "num_compound_or_double_hets": [
      "The patient has compound heterozygous mutations in WARS2 (p.Trp13Gly, p.Ser228Trp), which means he has two different mutations in the WARS2 gene.",
      "The patient is described as compound heterozygous for two variants in WARS2 (c.37T>G and c.683C>G), with each inherited from a different parent.",
      "The report describes the patient with 'compound heterozygous mutations in WARS2.'",
      "Biallelic mutations imply a compound or double heterozygote, indicating at least one such case."
    ]
  },
  "gene_symbol": [
    [
      "AR",
      "B14",
      "CAD",
      "CS",
      "EPOR",
      "GAA",
      "GATC",
      "GC",
      "GCA",
      "GCAT",
      "HR",
      "MAF",
      "MET",
      "MT-ATP6",
      "NDUFB8",
      "NHS",
      "PC",
      "PINK1",
      "Q10",
      "SDHA",
      "SI",
      "TG",
      "TH",
      "TRO",
      "UQCRC2",
      "WARS2"
    ],
    [
      "AR",
      "ATP6",
      "B2M",
      "CAD",
      "CS",
      "CUL4A",
      "FRY",
      "GCH1",
      "LRCH2",
      "MSC",
      "NDUFB8",
      "PC",
      "PINK1",
      "PRKN",
      "PS1",
      "SETD6",
      "SI",
      "UQCRC2",
      "WARS2"
    ],
    [
      "AARS2",
      "AR",
      "C2",
      "CS",
      "FER",
      "GEM",
      "ISCU",
      "MT-ATP6",
      "NDUFB8",
      "NHS",
      "NTS",
      "PC",
      "Q10",
      "REN",
      "SDHA",
      "SI",
      "UQCRC2",
      "WARS2"
    ],
    [
      "AARS2",
      "AR",
      "CS",
      "KIAA0586",
      "POR",
      "SLC25A4",
      "SLC39A14",
      "TARS2",
      "VARS2",
      "WARS2"
    ]
  ],
  "genomic_hgvs": [
    [],
    [],
    [],
    []
  ]
}